
Cancer. The body changes. The terrain changes. The rules change. Making sense of biological shifts in remission through lived experience and structured reasoning.
| Platform | Pricing | Freemium | Publishes | Twice weekly | |
|---|---|---|---|---|---|
| Issues | 48 | Founded | 6 months ago | Last Issue | 5 days ago |
| Active | |||||

The cell-death pathway that may expose a weakness in treatment-resistant cancer and the compounds that can trigger it
Cancer cells are very good at staying alive.
Let me tell you about this woman I knew of. She’s not here anymore to tell her story. I want to tell it for her.
She had triple-negative breast cancer (TNBC), one of the more aggressive forms of breast cancer. TNBC lacks estrogen, progeste...
Daily supplement, senolytic pulse, phytosome or IV? They are not the same strategy.
It can slow cancer signaling, reduce angiogenesis, promote apoptosis and may even help clear some treatment-induced senescent cells.
Chemotherapy and radiation do not just kill cancer cells. They also damage normal, healthy cells nearby.
Some of those damaged cells do not die off the way they are supposed to. These are not cancer cells. They are normal cells from skin,...
I had a completely different article planned for today. Then this news broke.
A landmark French court decision recognized a former Air France flight attendant’s breast cancer as an occupational disease, a first for the country’s aviation i...
Subscribers, engagement, traffic and sponsorship for The Cancer Strategist.
| Subscribers | Engagement | 79 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Integrative cancer strategies: what works, what doesn’t and what can backfire. Double MSc, analyst — I look at what the research says and what life actually teaches. From diagnosis to remission, I’m tracking this in real time.
You can find recent issues that have been published by The Cancer Strategist on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to The Cancer Strategist, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch The Cancer Strategist as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The Cancer Strategist using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like The Cancer Strategist. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.